TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $513M (100.0% shares, 0.0% debt)

Holdings (22)

— IVERIC BIO INC 24.4%
Value $125M Shares 5,141,118 Share Price $24.33 Est. Cost/Share $17.57 Unrealized @ Report Date —
COGT COGENT BIOSCIENCES INC 7.6%
Value $39.18M Shares 3,631,042 Share Price $10.79 * Est. Cost/Share $8.48 Unrealized @ Report Date +50.9%
GERN GERON CORP 7.5%
Value $38.55M Shares 17,765,213 Share Price $2.17 * Est. Cost/Share $1.57 Unrealized @ Report Date +80.8%
MDGL MADRIGAL PHARMACEUTICALS INC 7.1%
Value $36.32M Shares 149,917 Share Price $242.26 * Est. Cost/Share $94.85 Unrealized @ Report Date +187.3%
TYRA TYRA BIOSCIENCES INC 6.2%
Value $31.96M Shares 1,989,103 Share Price $16.07 * Est. Cost/Share $12.71 Unrealized @ Report Date -6.4%
VTYX VENTYX BIOSCIENCES, INC 5.3%
Value $27.33M Shares 815,724 Share Price $33.50 * Est. Cost/Share $29.94 Unrealized @ Report Date +29.9%
KALV KALVISTA PHARMACEUTICALS, INC 5.2%
Value $26.69M Shares 3,395,495 Share Price $7.86 * Est. Cost/Share $5.36 Unrealized @ Report Date +39.3%
— CYMABAY THERAPEUTICS INC 5.2%
Value $26.58M Shares 3,048,257 Share Price $8.72 Est. Cost/Share $3.38 Unrealized @ Report Date —
— VECTIVBIO HOLDING AG 5.2%
Value $26.5M Shares 3,113,600 Share Price $8.51 Est. Cost/Share $8.63 Unrealized @ Report Date —
— AEROVATE THERAPEUTICS INC 4.3%
Value $21.81M Shares 1,081,274 Share Price $20.17 Est. Cost/Share $14.29 Unrealized @ Report Date —
DYN DYNE THERAPEUTICS, INC 3.7%
Value $19.01M Shares 1,650,150 Share Price $11.52 * Est. Cost/Share $12.99 Unrealized @ Report Date 0.0%
KURA KURA ONCOLOGY INC 3.4%
Value $17.41M Shares 1,423,642 Share Price $12.23 * Est. Cost/Share $14.54 Unrealized @ Report Date -14.2%
VRDN VIRIDIAN THERAPEUTICS, INC 3.3%
Value $16.88M Shares 663,610 Share Price $25.44 * Est. Cost/Share $18.63 Unrealized @ Report Date +72.1%
SLN SILENCE THERAPEUTICS PLC 2.5%
Value $13.05M Shares 2,104,875 Share Price $6.20 Est. Cost/Share $10.03 Unrealized @ Report Date —
IMVT IMMUNOVANT, INC 2.0%
Value $10.16M Shares 654,853 Share Price $15.51 * Est. Cost/Share $12.59 Unrealized @ Report Date +37.8%
TRDA ENTRADA THERAPEUTICS INC 1.7%
Value $8.482M Shares 584,955 Share Price $14.50 Est. Cost/Share $17.12 Unrealized @ Report Date —
GPCR STRUCTURE THERAPEUTICS INC 1.6%
Value $8.326M Shares 350,000 Share Price $23.79 Est. Cost/Share $23.79 Unrealized @ Report Date —
— MERUS BV 1.1%
Value $5.52M Shares 300,000 Share Price $18.40 Est. Cost/Share $30.46 Unrealized @ Report Date —
ACRS ACLARIS THERAPEUTICS INC 0.8%
Value $4.286M Shares 529,839 Share Price $8.09 * Est. Cost/Share $15.07 Unrealized @ Report Date -15.8%
CABA CABALETTA BIO, INC 0.8%
Value $4.026M Shares 486,795 Share Price $8.27 * Est. Cost/Share $3.64 Unrealized @ Report Date +157.1%
CCCC C4 THERAPEUTICS, INC. 0.8%
Value $3.925M Shares 1,250,000 Share Price $3.14 * Est. Cost/Share $5.89 Unrealized @ Report Date 0.0%
— ALPINE IMMUNE SCIENCES INC 0.4%
Value $1.954M Shares 253,069 Share Price $7.72 Est. Cost/Share $13.85 Unrealized @ Report Date —